Lorence H. Kim's most recent trade in Revolution Medicines Inc was a trade of 11,574 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 11,574 | 11,574 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 3,142 | 73,090 (0%) | 0% | 0 | Common Stock | |
| Cencora | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 789 | 3,524 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 16,700 | 16,700 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 15,955 | 15,955 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,800 | 70,500 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,248 | 69,948 (0%) | 0% | 0 | Common Stock | |
| Cencora | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 843 | 2,735 (0%) | 0% | - | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 18,400 | 18,400 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 5,200 | 65,700 (0%) | 0% | 0 | Common Stock | |
| Cencora | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,334 | 1,892 (0%) | 0% | - | Common Stock | |
| Cencora | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 558 | 558 (0%) | 0% | 0 | Common Stock | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 22 Jul 2022 | 50,000 | 60,500 (0%) | 0% | 20 | 1,000,000 | Common Stock |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 36,800 | 36,800 | - | - | Stock Option (Right to Buy) | |
| Revolution Medicines Inc | Lorence H. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 10,500 | 10,500 (0%) | 0% | 0 | Common Stock |